Bellalgin tablets blister 10pcs

Composition

active ingredients: 1 tablet contains metamizole sodium salt in terms of anhydrous substance – 250 mg, benzocaine – 250 mg, sodium bicarbonate – 100 mg, thick belladonna extract ((4.8-5.2):1) (Belladonnae extractum spissum) (extractant 20% (v/v ethanol)) – 15 mg;

Excipients: microcrystalline cellulose, mannitol (E421), croscarmellose sodium, magnesium stearate, colloidal anhydrous silicon dioxide.

Release form

Pills.

Due to the m-cholinoblocking effect of belladonna extract, the drug reduces the tone and motor activity of smooth muscles of the gastrointestinal tract and other organs, reduces the secretion of exocrine glands. The analgesic effect of the drug is due to the effects of metamizole sodium and local anesthetic – benzocaine. Sodium bicarbonate neutralizes free hydrochloric acid in the stomach.

Dyspeptic phenomena (heartburn, belching, epigastric pain, intestinal colic) in hyperacid gastritis (with increased acidity of gastric juice); gastric and duodenal ulcers; cholelithiasis; spastic colitis.

Bellalgin is intended for short-term symptomatic therapy, so the duration of its use is set individually. If the symptoms of the disease do not pass within 3-5 days, it is necessary to review the treatment tactics. The drug is used orally, 1 tablet 2-3 times a day after meals. Higher doses for adults: single – 3 tablets, daily – 10 tablets.

Hypersensitivity to the ingredients of the drug, glaucoma, chronic liver and kidney diseases, benign prostatic hyperplasia, hematopoiesis suppression, neutropenia, pregnancy, age up to 18 years.

At that dose, the drug is usually well tolerated, however, the following side effects are possible.

On the part of the digestive system: dry mouth, thirst, constipation.

From the hematopoietic system: leukopenia, thrombocytopenia, agranulocytosis (due to metamizole sodium, which is part of the drug).

Allergic reactions: urticaria, angioedema.

From the nervous system: dizziness, weakness, headache, sleep disorders, agitation.

On the part of the organ of vision: mydriasis is possible.

Cardiovascular system: tachycardia is possible.

Use during pregnancy or breastfeeding.

The drug is contraindicated during pregnancy. If necessary, breastfeeding should be discontinued.

The use of the drug is not recommended in patients whose activities require high concentration of attention and quick reactions.

There are no clinical data on the efficacy and safety of use in children, therefore Bellalgin should not be prescribed to patients under 18 years of age.

The effect of metamizole sodium is enhanced by codeine, H2-receptor blockers, and propranolol.

Simultaneous administration with other non-narcotic analgesics, tricyclic antidepressants, hormonal contraceptives and allopurinol may lead to increased toxic effects. Metamizole, displacing oral hypoglycemic drugs, indirect anticoagulants, glucocorticosteroids and indomethacin from protein binding, increases their activity.

The manifestations of side effects are increasing.

In a dry place, protected from light, at a temperature of 15-25 °C.